Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells
about
Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer ImmunotherapyNewtonian cell interactions shape natural killer cell educationFrom scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancerNatural killer cells in human cancer: from biological functions to clinical applicationsHuman NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 ReceptorDNAM-1 control of natural killer cells functions through nectin and nectin-like proteins.Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade.Natural Killer Cells Response to IL-2 Stimulation Is Distinct between Ascites with the Presence or Absence of Malignant Cells in Ovarian Cancer Patients.Expression of CD226 is associated to but not required for NK cell education.Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.NK cell phenotypic modulation in lung cancer environment.The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes.Balancing natural killer cell activation through paired receptors.ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cellsIdentification of hepatic microvascular adhesion-related genes of human colon cancer cells using random homozygous gene perturbation.DNAM-1-based chimeric antigen receptors enhance T cell effector function and exhibit in vivo efficacy against melanoma.B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape.Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer.CD226 gene polymorphisms are associated with non-small-cell lung cancer in the Chinese Han population.Extravillous trophoblast and decidual natural killer cells: a remodelling partnership.Tumor microenvironment in NSCLC suppresses NK cells function.Generation and preclinical characterization of an NKp80-Fc fusion protein for redirected cytolysis of natural killer (NK) cells against leukemiaComparative study of various subpopulations of cytotoxic cells in blood and ascites from patients with ovarian carcinoma.Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma.Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulationATM activation mediates anticancer immunosurveillance by natural killer and T cellsEnhanced interaction between natural killer cells and lung cancer cells: involvement in gefitinib-mediated immunoregulation.IL-18-primed helper NK cells collaborate with dendritic cells to promote recruitment of effector CD8+ T cells to the tumor microenvironment.Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.Natural Killer Group 2, Member D/NKG2D Ligands in Hematopoietic Cell Transplantation.NK cell recognition and killing of melanoma cells is controlled by multiple activating receptor-ligand interactions.Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands.Human NK cell receptors/markers: a tool to analyze NK cell development, subsets and function.At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.Cytotoxic and immunogenic mechanisms of recombinant oncolytic poliovirusOncolytic immunotherapy through tumor-specific translation and cytotoxicity of poliovirus.Oncolytic viruses: a new class of immunotherapy drugs.Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas.Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy.Immunotherapy for advanced melanoma: future directions.
P2860
Q26772347-6565EF66-4F54-4DE4-9BD9-1316E36820C5Q26797240-0F909163-B706-4215-A51F-2554E735C72DQ26822694-9EB78482-40A7-4F7C-963A-E6033721AA88Q27691427-F427B3E4-4593-4D4C-AD98-B95DEEF8A2CCQ28067468-0D9CF206-4965-4389-ADEA-A118C792402CQ30716850-BB6E28D2-5785-41B3-B0D3-615C6DB9B926Q33714165-146A5E01-EBA2-4AE0-85E7-2AEC8CA4C73EQ33754724-07264A92-544B-4087-A57A-4273390979DBQ33766787-4738DB7C-D309-4285-8049-8FB549BC135FQ34016504-7C7A7895-E4BA-44B4-9B42-EE702141417CQ34316837-E1C0306E-C8BB-48EE-A707-BA23A173E7AAQ34411026-720D54FC-3B25-4C1A-9265-501FE1BB85AEQ34465877-530209DE-C132-4357-930A-554742A586F8Q34660118-6877F311-7BE1-4941-BEFD-BE29D8F90904Q34694964-C78FC476-C839-4331-B8C7-44D79CDEBCE2Q35209066-B592FF9D-8D09-4923-83FB-C7C34A73362CQ35798978-9087A5B8-A739-403E-9CEA-A94871273112Q35987354-444E1C0E-B8A0-45DB-B99E-E3D021EB92A3Q36010404-6D5EF63B-8EBE-4F24-8244-0871B901C4D7Q36026812-0BCD9836-810A-4A4B-8AF7-D1EC0446ECFBQ36038484-8BE6B39D-9F4E-4CA7-A4AF-C6DE5FE44832Q36049914-30799EEC-2C8C-4E6C-AABB-36018AFA2B2EQ36244004-7CD3A52B-298F-479B-A7A3-F52554B0616DQ36339260-A7F1F31E-0EC0-4269-AEA8-B36543F09439Q36957280-E42011AF-D746-45CB-9980-642F77305D7FQ37028006-C48513B1-60F7-4856-A8A8-F51D06F33879Q37155165-E76C7B1C-9F51-4EFC-B2F2-969A14171791Q37191088-B0B93E3C-668B-4D6C-88B5-CF8FF43947FDQ37629088-6FD0D487-4BE6-4B7E-B99C-47915D621F79Q37721591-CB2749AF-BEAC-43DD-977C-31C3A0206A67Q37876096-862D8DDE-47F1-4ECC-B3B6-F13AFD210223Q37885284-735E7627-7401-4871-B76A-7ED859ADC9C0Q38104708-F27F7667-51B1-4887-9A2A-CB0429359B34Q38151057-F53210BF-3D5C-44AD-B9B0-2C27DBE5AA64Q38530234-0A246765-8DA8-40C2-B6AD-2D81C90DEC81Q38536420-309F67C8-7D25-4CB1-ACC2-EA90BF04CF62Q38577450-5236E9A9-F963-41A2-82FB-3E379ED30E14Q38614523-4538747C-6C6A-44B4-BDF5-7B0D3CC715A1Q38636569-6489DA53-5940-435E-BB1B-7E840FB87B2EQ38711163-6F69B101-EE2B-4EF2-84BE-D1E28161218C
P2860
Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Primary human tumor cells expr ...... -regulating DNAM-1 on NK cells
@ast
Primary human tumor cells expr ...... -regulating DNAM-1 on NK cells
@en
Primary human tumor cells expr ...... -regulating DNAM-1 on NK cells
@nl
type
label
Primary human tumor cells expr ...... -regulating DNAM-1 on NK cells
@ast
Primary human tumor cells expr ...... -regulating DNAM-1 on NK cells
@en
Primary human tumor cells expr ...... -regulating DNAM-1 on NK cells
@nl
prefLabel
Primary human tumor cells expr ...... -regulating DNAM-1 on NK cells
@ast
Primary human tumor cells expr ...... -regulating DNAM-1 on NK cells
@en
Primary human tumor cells expr ...... -regulating DNAM-1 on NK cells
@nl
P2093
P50
P3181
P356
P1476
Primary human tumor cells expr ...... -regulating DNAM-1 on NK cells
@en
P2093
Hans-Gustaf Ljunggren
Isabel Poschke
Kjell Schedvins
Rolf Kiessling
P304
P3181
P356
10.4049/JIMMUNOL.0901226
P407
P577
2009-10-01T00:00:00Z